DIRECTOR APPOINTMENT

TIDMOPTS

Optos plc

13 December 2011

OPTOS PLC

(the "Company")

DIRECTOR APPOINTMENT

LONDON, UK, 13 December 2011 - Optos PLC (LSE: OPTS), a leading retinal imaging company, is today confirming that John G. Goddard, a Non-Executive Director of the Company, has been appointed as a Director of MELA Sciences, Inc. (NASDAQ: MELA), with effect from 08 December 2011. This announcement is intended to fulfill the Company's continuing obligations under LR 9.6.14(2). No further disclosures are required under the Listing Rules with respect to the appointment.

FOR AND ON BEHALF OF OPTOS PLC

John McNeil

Company Secretary

Forward-Looking Statements

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates and projections about its industry, its beliefs and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors, some of which are beyond the Company's control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAEAFADFSFFFAF